The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Ibuprofen Bril 200 mg film-coated tablets



Brillpharma (Ireland) LimitedPA22749/022/001

Main Information

Trade NameIbuprofen Bril 200 mg film-coated tablets
Active SubstancesIbuprofen
Dosage FormFilm-coated tablet
Licence HolderBrillpharma (Ireland) Limited
Licence NumberPA22749/022/001

Group Information

ATC CodeM01AE Propionic acid derivatives
M01AE01 ibuprofen

Status

License statusAuthorised
Licence Issued25/01/2019
Legal statusProduct not subject to medical prescription
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to the general public
Conditions of LicenceSupply through pharmacies only subject to the following restrictions: maximum strength 200mg, maximum pack size 50, maximum dose 400mg, maximum daily dose 1200mg, limited indications. Promotion to the public subject to the following restrictions: maximum strength 200mg, maximum pack size 50, maximum dose 400mg, maximum daily dose 1200mg, limited indications.
Marketing StatusNot marketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back